Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-40.83	-108.41	183.21
Graham Fair Price	228.77	10.48	3.19
PEG	-99.36	< 0.005	-0.38
Price/Book	-10.61	0.89	1.00
Price/Cash Flow	94.42	26.72	-13.74
Prices/Earnings	-91.95	-2.89	35.94
Price/Sales	4.53	1.15	1.10
Price/FCF	94.42	26.72	-13.74
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-87.67	-0.01	0.10
Operating Margin	-129.55	-0.12	-0.05
ROA	967.83	-0.02	< 0.005
ROE	< 0.005	-0.08	1010.35
ROIC	-0.02	-0.03	-47.80
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	-0.03	64.52
Dividends QOQ	1.00	4.00	300.77
EBIT QOQ	-1.34	-0.94	29.95
EPS QOQ	-0.94	-11.89	-1159.84
FCF QOQ	-2.54	1.45	-42.71
Revenue QOQ	-0.15	-0.16	-6.05
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	10.99	11.74	6.74
Days Sales Outstanding (DSO)	46.66	60.01	28.62
Inventory Turnover	8.19	7.67	-6.32
Debt/Capitalization	0.55	0.59	7.60
Quick Ratio	0.65	0.57	-11.66
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	8.07	7.96	-1.33
Cash	6.91	6.91	0.11
Capex	-1.11	-0.83	25.22
Free Cash Flow	-0.59	0.27	-54.64
Revenue	7.32	6.18	-15.62
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.79	0.74	-5.83
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	102.94	-64.62	-37.23
Naive Interpretation	Member

06 - Financial Health · Bad

Rating